SNCB antibody
Product Specifications
Background
Non-amyloid component of senile plaques found in Alzheimer disease. Could act as a regulator of SNCA aggregation process. Protects neurons from staurosporine and 6-hydroxy dopamine (6OHDA) -stimulated caspase activation in a p53/TP53-dependent manner. Contributes to restore the SNCA anti-apoptotic function abolished by 6OHDA. Not found in the Lewy bodies associated with Parkinson disease.
Synonyms
Beta-synuclein|SNCB
Gene ID
6620
UniProt
Q16143
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
Synuclein, beta
Target
SNCB
Clonality
Polyclonal
Isotype
IgG
Applications
ELISA, WB, IHC, IF, FC
Field of Research
Neuroscience
Purification
Immunogen affinity purified
Dilution
WB: 1:500-1:1000; IP: 1:500-1:1000; IHC: 1:10-1:100; IF: 1:10-1:100
Purity
≥95% as determined by SDS-PAGE
Form
Liquid
Molecular Weight
14-18 kDa
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
Tested Applications
ELISA, WB, IHC, IF, FC
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15151396 1 Vial
Lentiviral human AQP5 shRNA (UAS) - Lentiviral human AQP5 shRNA (UAS, iRFP) plasmid
Ask
View Details 
